Menu Close

News & Events

Lazarex news icon
< Timeline >
February 10, 2023
Power Station podcast with Ann Pasmanick interviewing Dana Dornsife, Lazarex Cancer Foundation Founder and Chief Mission and Strategy Officer, about LCF programs, advocacy and efforts for racial and community equity re cancer health and access to care.
Learn More
January 4, 2023
Women Less Satisfied With Cancer Care (Cancer Today Magazine) Lazarex Cancer Foundation CEO Stephanie Rivera opens up about her thyroid cancer diagnosis, being dismissed, and finding her voice.
Learn More
< Timeline >
October 5, 2022
CAPE GIRARDEAU, Mo. – A man near Cape Girardeau who donates free car rides for cancer patients now needs that very thing – and more. A remarkable charity is stepping up so this volunteer can keep living and keep giving.
Learn More
September 28, 2022
Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates #SB987
Learn More
July 27, 2022
Stephanie Rivera , CEO, Lazarex Cancer Foundation, joins Yo to discuss how the Foundation’s efforts to address the gap and barriers in accessing cancer trials for minority populations. This Foundation leads the way to improve cancer health outcomes, FDA cancer clinical trial diversity and enrollment, and..
Learn More
July 17, 2022
Clayton Woman Battles Rare Cancer. Receiving a cancer diagnosis is always devastating. But for Rhonda Long of Clayton, the road just to get to a definitive diagnosis was long and difficult. Because bile duct cancer is rare, there aren’t many programs established to help patients diagnosed with it. But Lazarex Cancer Foundation offered lodging and transportation assistance when she started her second clinical trial.
Learn More
May 13, 2022
Group works to get more people of color involved in clinical drug trials by covering costs. The FDA says people of color are underrepresented in medical research. KOCO News 5
Learn More
< Timeline >
August 26, 2021
Lazarex Cancer Foundation Receives National Healthcare Award from Health Industry Leaders
Learn More
July 30, 2021
Philadelphia Pilot Program To Bridge Gap Between Patient and Provider: Great piece about Lazarex Cancer Foundation’s Community Impact Program at the Dornsife Center at Drexel University.
Learn More
July 13, 2021
Black cancer patients are often left out of life-saving #clinicaltrials, but a national non-profit is helping to change those inequities.
Learn More
June 15, 2021
Disrupting the System IV: Lazarex and Medidata hosted some of the biggest disruptors and innovators in oncology, patient advocacy and public policy who are working to make cancer research accessible to all.
Learn More
May 31, 2021
There are efforts to improve diversity in cancer trials: One of the silver linings of the pandemic is that COVID vaccine trials recruited more diverse participants. But it’s still an uphill battle in many other areas of medicine. With Dr. Marya Shegog, Health Equity and Diversity Coordinator for Lazarex Cancer Foundation.
Learn More
May 24, 2021
USC Norris Comprehensive Cancer Center to establish the Cancer Wellness HUBs with Lazarex Cancer Foundation grant
Learn More
May 21, 2021
The Abramson Cancer Center at the University of Pennsylvania (ACC) has succeeded in more than doubling the enrollment of Black patients into cancer clinical trials following a five-year community outreach plan and will present the results at the American Society of Clinical Oncology annual meeting on June 5.
Learn More
May 19, 2021
Penn’s Abramson Cancer Center Doubles the Percentage of Black Participants in Clinical Trials: The ACC has collaborated with Lazarex Cancer Foundation to implement its IMPACT program, a first-of-its-kind effort at the ACC combining financial reimbursement for travel related expenses, outreach, and educational programs to help patients with cancer learn about and access advanced treatment in clinical trials.
Learn More
May 10, 2021
IMPROVING ACCESS TO CANCER CLINICAL TRIAL PROGRAMS IN MASSACHUSETTS: A new law in Massachusetts is set to eliminate a major financial barrier to accessing clinical trials. Lazarex Cancer Foundation developed a clinical trial bill that expands access to care in Massachusetts.
Learn More
April 4, 2021
Lazarex Cancer Foundation Created a Program to Include More People of Color in Human Trials (PODCAST) One important example of implicit bias in health care is human trials. KCBS Radio’s Rebecca Corral tells us about a program aimed at including more people of color in this life-saving research.
Learn More
April 2, 2021
Lazarex Cancer Foundation’s new Cancer Wellness Hub is a safe space for community members to talk about their questions in relation to the entire continuum of cancer care. Founder and CEO DanaDornsife joins Michael Toscano on First Light to explain (starts @ 18:00) #MinorityHealthMonth
Learn More
March 23, 2021
Lazarex Cancer Foundation Health Equity and Diversity Coordinator Dr. Marya Shegog talks with WebMD about the lack of diversity in cancer clinical trials.
Learn More
February 2021
Lazarex Cancer Foundation Founder and CEO Dana Dornsife weighs in on why there’s a disconnect between patients with cancer who need to join a clinical trial to survive and the many clinical trials that need patients to participate in them to be able to succeed.
Learn More
< Timeline >
December 30, 2020
December Newsletter: Video message from Lazarex COO Vera Packard, What I Am Grateful For In 2020 by Lazarex founder and CEO Dana Dornsife, LCF Patient Gail’s update, Meet Marya L. Shegog, PhD, MPH, CHES: Lazarex Health Equity and Diversity Coordinator, 2020 Year End Appeal, Major Victory for Thousands of Massachusetts Cancer Patients.
Learn More
December 7, 2020
Improving Patient Access to Cancer Clinical Trials: A podcast with Lazarex founder and CEO, Dana Dornsife. If you are interested in the issue of disparities in healthcare and improving patient access to clinical trials, this episode is one you shouldn’t miss.
Learn More
November 2020
November Newsletter: Giving Tuesday; LCF patient Matthew’s Story, Darlene Chiang new BOD member, Lazarex PATH program introduction, Democratizing Clinical Trials with Dana Dornsife of Lazarex Cancer Foundation, LCF program stats.
Learn More
November 18, 2020
Physicians Guide to Doctoring Podcast: Democratizing Clinical Trials with Dana Dornsife of Lazarex Cancer Foundation
Learn More
October 30, 2020
Barriers to Clinical Trial Participation: Patient Empowerment Network series of interviews with Dana Dornsife, founder of Lazarex Cancer Foundation, about the key barriers to clinical trial participation, what are virtual trials, and how COVID-19 has really opened the door for a lot of opportunity to engage with patients around clinical trials.
Learn More
October 2020
October Newsletter: Lazarex Gala recap, In Memory of Chip Hollister, Introducing Lazarex PATH – a new Lazarex Program, Lazarex in the News – How Dana Dornsife of Lazarex Cancer Foundation Is Helping To Improve The Outcome of Cancer Care, Lazarex in the News – WBALTV 11: Coronavirus pandemic exposes hard truths about racial disparities in the healthcare industry, Write a Review to Help Lazarex be a Top Rated Nonprofit in 2020.
Learn More
October 23, 2020
CISCRP Honors “Medical Heroes,” Participants in Clinical Trials: The AWARE for All online event featured a keynote and overview presentation followed by a panel discussion; virtual health exercises. Panel discussions included LCF Board Member Jonathan Jackson and LCF client Ashely Kulp.
Learn More
October 14, 2020
“The Cancer Problem That No One’s Talking About”: The Cost of Traveling to Clinical Trials with Lazarex founder and CEO Dana Dornsife and Lazarex patient Jackie Hinckley.
Learn More
Ocotober 13, 2020
Social Impact Heroes on ThriveGlobal Magazine: Dana Dornsife: “Always put people first.” How Dana Dornsife of Lazarex Cancer Foundation Is Helping To Improve The Outcome of Cancer Care.
Learn More
October 9, 2020
Social Impact Heroes on Authority Magazine: How Dana Dornsife of Lazarex Cancer Foundation Is Helping To Improve The Outcome of Cancer Care
Learn More
October 2, 2020
Press Release: “Lazarex Cancer Foundation and Oncopeptides Partner to Remove Financial Barriers to Oncopeptides’ sEAPort Expanded Access”
Learn More
October 1, 2020
Press Release: Oncopeptides initiates U.S. Expanded Access Program with melflufen in triple-class refractory multiple myeloma. Lazarex PATH program for trial participants reimbursements.
Learn More
September 2020
Treasure the Moments – Shhh! It’s a Speakeasy! Gala recap with links to photos and videos.
Learn More
September 24, 2020
Press Release: New Study Puts Spotlight on Major Health Disparities – A new report sponsored by Lazarex Cancer Foundation calls attention to the serious disparities in cancer rates and outcomes. The “State of Cancer in Philadelphia” was issued this week as a collaboration between Drexel University’s Urban Health Collaborative, the Philadelphia Department of Public Health, and the Fox Chase Cancer Center.
Learn More
September 18, 2020
WBALTV 11: Coronavirus pandemic exposes hard truths about racial disparities in the healthcare industry. With Lazarex client Rhonda Long and founder Dana Dornsife.
Learn More
September 14, 2020
WCNC – ‘Those numbers are too low’ | Charlotte coronavirus vaccine trials call for more representation in participants. With Lazarex founder Dana Dornsife.
Learn More
September 11, 2020
BioTech IQ Podcast: When Dana’s brother-in-law was diagnosed with pancreatic cancer she helped her family discover the power of access to clinical trials. That led her founding Lazarex Cancer Foundation, a non-profit organization that helps people find clinical trials and deal with the costs associated. Dana has literally worked to induce change on how the FDA views reimbursements to patients from pharma companies and her foundation is doing some amazing things to further diversity. Listen for the whole story!
Learn More
August 2020
August Newsletter: Treasure the Moments Gala 2020, VIP Sofia’s Story, Lazarex Program Update, Recap of Disrupting the System III, WCNC News – Inequality in America, Book Your Flights on Southwest with SWAbiz…
Learn More
August 20, 2020
WebMD: Coronavirus in Context: Will COVID Ultimately Make Clinical Trials More Diverse?
Learn More
August 14, 2020
STATS News: Covid-19 clinical trials are failing to enroll diverse populations, despite awareness efforts
Learn More
August 7, 2020
The Kelly Wright Show from Washington DC – discussion addressing Covid-19 and Cancer disparities in the Black and Brown communities with Lazarex patient Rhonda Long and Dana Dornsife, Lazarex founder and CEO.
Learn More
July 28,2020
WCNC Inequality in America piece on The Importance for Clinical COVID-19 Trials to Reflect the Population at Large – with Lazarex Cancer Foundation.
Learn More
May 2020
May Newsletter: 1 Habit to Beat Cancer Online Summit, 5.44K recap, Passages – In Memory of Jackie Hinckley, A Video Message of Gratitude from Dana Dornsife, Covid Updates, Donate your United Miles, Latest Lazarex In the News..
Learn More
April 21, 2020
Virtual Clinical Trials for COVID-19 Could Change Study of Other Diseases: Doreen Gentzler of NBC4 Washington interviews Lazarex patient Mike Snyder, Lazarex Cancer Foundation CEO Dana Dornsife, and Dr. Louis Weiner, Director of the Georgetown Lombardi Comprehensive Cancer Center.
Watch the Interview
April 17, 2020
Novel coronavirus opens the door for remote clinical trial participation: Micah Smith of ABC Denver7 interviews Lazarex founder & CEO Dana Dornsife, UCSF oncologist Dr. Hala Borno and Lazarex patient Mike Snyder about the changing landscape for clinical trial participation due to the coronavirus.
Watch the Interview
April 16, 2020
Helping Cancer Patients Access Clinical Trials During National Minority Cancer Awareness Week: As our nation addresses the COVID-19 pandemic and seeks to develop a vaccine, it has become abundantly clear how important clinical trials are. Radio interview and article with Dana Dornsife, Founder and CEO of Lazarex Cancer Foundation.
Listen to the Interview
April 15, 2020
Clinical Trial Participation Act Aims To Ease Patient Reimbursement For Trials: A non-profit foundation is spearheading legislation that give thousands of underserved and hopeful cancer patients access to clinical trials and potential life-saving drugs. The Clinical Trial Participation Act reiterates FDA guidance that reimbursing patients for out-of-pocket travel expenses associated with cancer clinical trials is not considered coercion or inducement.
Read the Article
April 9, 2020
KTVU’s Claudine Wong in conversation with UCSF’s Dr. Hala Borno, Dana Dornsife and Lazarex Cancer Foundation VIP (Very Important Patient) Becky Stephens on the new rules of engagement regarding how we conduct cancer clinical trials in the face of COVID-19 and what it could mean for patients moving forward.
Watch the Interview
March 31, 2020
The Covid-19 pandemic is forcing cancer trials to get creative, accelerating changes patient advocates have long sought to make it easier for more people to join the studies.
Learn More
March 2020
March Newsletter: Covid-19 update; Can Our COVID-19 Experience Create a “New Normal” for the Cancer Clinical Trial Landscape? from Dana Dornsife; Business as “Unusual” video from Vera Packard; Lazarex 5.44K Now a Virtual Event; Lazarex Blog …
Newsletter
March 11, 2020
Among the flurry of bills signed into law by Gov. Tony Evers last week, one that didn’t get much attention stands to help cancer patients and their families throughout Wisconsin. The bill, SB 489, passed on voice votes in both the Assembly and Senate with full bipartisan support, addresses economic barriers faced by cancer patients to participate in life-sustaining clinical trials.
Read the article
February 26, 2020
Lazarex Cancer Foundation and Perthera unite to advance Clinical Trial Access and Enrollment for Cancer Patients. They will be focused on matching and enrolling patients in clinical trials through Lazarex IMPACT and CARE programs, by utilizing Perthera’s treatment-matching Artificial Intelligence (AI) technology and other elements of the Perthera Platform to advance precision medicine for cancer patients.
Press Release
February 26, 2020
The Ritz Herald: llinois Lawmakers announce a new law that will help thousands of cancer patients in the state. SB1711, the Clinical Trial Participation Act gives all Illinois cancer patients new hope by providing access to potentially life-saving breakthrough medical advancements in clinical trials.
Read the Article
February 24, 2020
Major Victory For Cancer Patients In Illinois: Illinois Lawmakers announce a new law that will help thousands of cancer patients in the state. SB1711, the Clinical Trial Participation Act gives all Illinois cancer patients new hope by providing access to potentially life-saving breakthrough medical advancements in clinical trials.
Press Release
February 24, 2020
NBC 5 Chicago: Clinical trials can save the lives of cancer patients, but studies show minorities and the poor often don’t participate, because they simply can’t afford to. Parking costs and travel expenses add up, but a new law in Illinois allows patients to get reimbursed for those expenses. Includes interview with Lazarex Cancer Foundation’s Dana Dornsife.
Watch the Video
February 24, 2020
WTTW PBS Chicago Tonight interview with Dana Dornsife, Founder of Lazarex Cancer Foundation; Dr. Leon Platanias, Director of the Northwestern University Robert H. Lurie Comprehensive Cancer Center; and Theresa Staten, who has been participating in a clinical drug trial with assistance from Lazarex Cancer Foundation, about The Cancer Clinical Trial Participation Act, Senate Bill 1711, recently signed into law.
Watch the Interview
February 24, 2020
Chicago Tribune: New law will provide Illinois cancer patients funds to attend clinical trials: The Clinical Trial Participation Act was formally announced Wednesday. The legislation, which was signed Dec. 20, aims to increase participation in clinical trials by removing primary barriers for patients, a big one being finances.
Read the Article
February 2020
February Newsletter: Clay Jackson, Board Chair; Clinical Trials and You: Interview with Glenn Ellis; Very Important Patient Theresa Staten; 2020 Lazarex 5.44K; Fridays with Vera …
Newsletter
February 7, 2020
Danville, CA Nonprofit Helps Patients Find Trials: KRON SF’s Terisa Estacio interviews Erin Miller of Lazarex Cancer Foundation about the foundation’s mission to help patients find and participate in FDA cancer clinical trials. #CancerPreventionMonth
Watch the Interview
February 5, 2020
All men are not created equal in the world of cancer. That is one message from Hala Borno, MD, PhD, a medical oncologist focusing on genitourinary malignancies at the UCSF Helen Diller Family Comprehensive Cancer Center. “I have a research interest in addressing disparities, the reflection of differences that lead to inequity,” she told Oncology Times.
Read the Article
January 30, 2020
Greenphire, the global leader in financial software for clinical trials, today announced that its CEO, Jim Murphy, will co-present alongside Lazarex Cancer Foundation Founder, Dana Dornsife, at the Society for Clinical Research Sites (SCRS)’s annual Global Oncology Site Solutions Summit.
Press Release
< Timeline >
December 19, 2019
Ed Miesta, Chief Editor of Clinical Leader, discusses Patient Diversity in Clinical Trials – the barriers for minority populations and initiatives to address the problem with Dana Dornsife (Lazarex Cancer Foundation), Stephanie Monroe (African Americans against Alzheimer’s) and Dr. Fabian Sandoval (Emerson Clinical Research Institute).
Read the Article
December 2019
December Newsletter: Thank You! Big Sur Int’l Marathon; Illinois Passes Cancer Clinical Trial Legislation; Dana Dornsife Receives NCCS Ellen Stovall Award; Get Involved…
Newsletter
December 16, 2019
Chicago’s WGN Radio 720 interview with Dana Dornsife and Lazarex patient Theresa Staten Host Anna Daviantes talks clinical trials, Lazarex programs and recent efforts to get a bill in Illinois signed into law. Forward to 59:08 to hear the Lazarex interview.
Learn More
December 5, 2019
Lazarex Cancer Foundation receives Danville Community Service Award. Founder Dana Dornsife accepts the award.
Learn More
November 13, 2019
NCCS Presents 4th Annual Ellen L. Stovall Award to Dr. Harmar Brereton and Dana Dornsife for Their Innovation and Dedication to Cancer Survivors Congressman Mark DeSaulnier (CA-11), a cancer survivor, presented the award to his constituent, Mrs. Dornsife. View the video honoring Dana Dornsife, Cancer Advocacy Innovator, at the award ceremony.
Learn More
November 3, 2019
Tri-Valley Hero: Danville’s Dana Dornsife, improving access to clinical trials The Pleasanton Weekly honors Lazarex Cancer Foundation’s Founder and Board Chair Dana Dornsife with the Role Model award at the Tri-Valley Heroes Awards Ceremony
Learn More
October 30, 2019
Lazarex Cancer Foundation is featured on PBS Newshour: Why minority representation in medical research is a matter of life and death. The country’s diversity is becoming ever greater, but medical research that could benefit the populace is not keeping pace. Special correspondent Cat Wise has the story.
Learn More
October 8, 2019
Cancer patients often need this one basic thing to participate in clinical trials The Philadelphia Inquirer’s Marie McCollough interviews Lazarex Cancer Foundation Founder Dana Dornsife about the foundations’s initiatives in Philadelphia.
Learn More
September 30, 2019
Wrapping Up the Lazarex Gala – Lazarex Cancer Foundation’s “Treasure the Moments” gala was a memorable evening for everyone who attended. With a full house of more than 200 guests, the event raised $291,980 (net) due to very generous and spirited giving! Read the RECAP here. Check out gala photos here.
Learn More
September 21, 2019
Lazarex Gala “Treasure the Moments” – Join us at Garré Vineyard & Winery in Livermore, CA .
Learn More
September 12, 2019
Lazarex Cancer Foundation’s founder Dana Dornsife receives Diablo Magazine’s “Agents of Change” Award. View photos here.
Learn More
September 5, 2019
Lazarex Development Manager Erin Miller sits down with AMGEN and The Washington Post Live to discuss IMPACT and clinical trials. Content from Amgen Oncology: Accelerating Discovery
Learn More
August 2019
August Newsletter: 2018 Annual Report; Treasure the Moments Gala; Patient Stories; Get Involved…
Newsletter
August 27, 2019
New Texas law will help cover some costs for cancer treatment patients Lazarex VIP (Very Important Patient) Charmaine Sarpong and Founder Dana Dornsife speak with Fox 4 Dallas reporter Dionne Anglin about the legislation in Texas that is effective 9/1 and will help 10’s of thousands of the state’s cancer patients gain access to clinical trials.
Learn More
August 23, 2019
Diablo Magazine Announces its 2019 AGENTS of CHANGE, 23 innovators, movers and shakers, and groundbreakers who are blazing trails in the East Bay and beyond. Dana Dornsife is among the honorees to be recognized at a reception on September 12, 2019.
Learn More
August 7, 2019
NCCS Announces 2019 Stovall Award Honorees, Dr. Harmar Brereton and Dana Dornsife. Read the press release here.
Learn More
August 6, 2019
Lazarex Cancer Foundation founder Dana Dornsife talks with Ann Pietrangelo about the costs associated with clinical trials.
Learn More
July 30, 2019
Founding IMPACT sponsor, AMGEN, welcomes Lazarex Cancer Foundation’s Dana Dornsife to their headquarters campus.
Learn More
June 2019
June Newsletter: Lazarex Programs Summary; Lazarex in the News; Texas Passes Cancer Clinical Trials Legislation; Lazarex Presenting at ASCO…
Newsletter
June 19, 2019
Dana Dornsife, the founder of one such organization, called the Lazarex Cancer Foundation, spoke on Good Day DC yesterday morning about how these financial barriers are “the cancer problem that no one’s talking about.”
Learn More
June 18, 2019
Lazarex Cancer Foundation hosted some of the biggest disruptors and innovators in oncology, patient advocacy and public policy to discuss making cancer research more accessible to ALL patients. View the video here. View the RECAP here.
Learn More
June 18, 2019
FOX 5’s Holly Morris sits down with Jackie Hinckley, a patient being helped by the Lazarex Cancer Foundation, and founder, Dana Dornsife.
Learn More
June 18, 2019
Lazarex Cancer Foundation applauds Texas lawmakers for passing a law to break barriers to cancer clinical trials and provide equal access to potentially life-saving breakthrough medical advancements.
Learn More
June 11, 2019
Cancer robbed Ellie of her hair but not her life. She is now 8 and a survivor. Lazarex Cancer Foundation helps Ellie’s family with travel expenses for trips to New York for her treatment.
Learn More
June 5, 2019
Building trust is key to improving diversity in clinical trials. At BIO Tuesday, panelists discussed the lack of racial, ethnic and gender diversity in clinical trials and its potential implications… the panel included Lazarex Cancer Foundation founder Dana Dornsife…
Learn More
June 4, 2019
How Cultural Competence Could Help Boost Diversity in Clinical Research – If studies lack diversity, we’ll lack a clear picture of whether a treatment will work in all populations… Dana Dornsife, founder of Lazarex Cancer Foundation, acknowledged that there is no one-size-fits-all solution…
Learn More
June 2019
Overcoming Financial Barriers to Clinical Trials Enrollment – The Coalition for Clinical Trials Awareness hosted a Washington, DC policy panel discussion on May 14 to explore the issue. Laura Evans Manatos of Lazarex Cancer Foundation was one of the four panelists.
Learn More
June 2019
Community, University, Industry Partner to Boost Minority Recruitment – A community-based initiative in West Philadelphia is blazing a trail for minority involvement in cancer trials, and academia and industry are signing on for the ride. See pages 1 & 5.
Learn More
May 30, 2019
USC researchers offer financial aid to increase participation in clinical trials. Researchers depend on a wide variety of people signing up for clinical trials, so they can get the most diverse results. But participating in research can be time-consuming and costly… Lazarex Foundation provides the funding…
Learn More
May 2019
May Newsletter: Lazarex in the News; IMPACT Launches at USC Norris & UCSF; Lazarex Gala Save the Date; Wrapping up Lazarex IMPACT 5.44K and the Big Sur Int’l Marathon …
Newsletter
May 24, 2019
Drexel and Lazarex Cancer Foundation Establish Program to Help Improve Health Outcomes for Philadelphia Neighborhoods – Drexel University is partnering with the Lazarex Cancer Foundation to establish Community IMPACT, a program that will focus on reducing cancer and …
Learn More
May 23, 2019
Navigating trial enrollment roadblocks for underrepresented populations. Dana Dornsife, founder of Lazarex Cancer Foundation, which is partnering on the IMPACT study, said in a statement, “The potential benefits of clinical …
Learn More
May 22, 2019
Lazarex Foundation Works To Achieve Minority Equity In Cancer Clinical Trials – Clinical Research News. The Lazarex Cancer Foundation is working to sustainably achieve minority equity and increased enrollment in cancer clinical trials nationwide by …
Learn More
May 14, 2019
Greenphire partners with Lazarex to ease oncology trial reimbursement. Lazarex partners with Greenphire to implement the latter’s ClinCard reimbursement technology to improve patient participation in oncology trials.
Learn More
May 13, 2019
Greenphire Forms Strategic Partnership with Lazarex Cancer Foundation to Support Its Oncology … Lazarex Cancer Foundation covers the costs for patients seeking to participate in oncology clinical trials, including airfare, ground transportation and …
Learn More
May 4, 2019
In Brief USC and UCSF join Lazarex in IMPACT program to increase diversity in trials. The Cancer Letter Publications USC Norris Comprehensive Cancer Center and UCSF Helen Diller Comprehensive Cancer Center joined a program with Lazarex Cancer Foundation …
Learn More
May 1, 2019
USC Clinical Trials You can start full episode at the top and fast forward to about 22:00 to hear Erin’s interview. The page also has a small blurb about IMPACT if you scroll down.
Learn More
May 1, 2019
Pierde la salud, su hogar y aunque gana una batalla, todavía teme por su familia. Clara Salas siempre había sido una mujer trabajadora e independiente, dedicada a mantener a sus cuatro hijos ya que es madre soltera. No obstante, hace dos años recibió un golpe devastador.
Learn More
April 30, 2019
USC Norris Launches Diversity-Driven Study Among Clinical Trial Participants – She is also the namesake of the USC Dana and David Dornsife College of Letters, Arts and Sciences. “With more than 1.5 million people receiving a …
Learn More
April 29, 2019
USC Norris Launches Breakthrough Program to Increase Diversity in Cancer Clinical Trials – IMPACT (IMproving Patient Access to Cancer Clinical Trials) is a first-of-its-kind program combining financial reimbursement, outreach, and …
Learn More
April 29, 2019
USC Norris launches study to increase diversity among clinical trial participants. She is also the namesake of the USC Dana and David Dornsife College of Letters, Arts and Sciences. “With more than 1.5 million people receiving a …
Learn More
April 26, 2019
Leveraging technology and digital tools to (finally) increase diversity in clinical trials. The nonprofit Lazarex Cancer Foundation is collaborating with University of California, San Francisco on a three-year study to improve cancer clinical …
Learn More
April 2019
April Newsletter: A symposium and reception was held at the UCSF campus to celebrate the pending April launch of the IMPACT Study; CBS4 Denver interviews LCF Patient Cindy Schlager; LCF IMPACT 5.44K …
Newsletter
April 16, 2019
UCSF Study Aims to Increase Diversity in Cancer Clinical Trials – UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial …
Learn More
April 10, 2019
Unique Charity Helps Cancer Patients Find And Access Clinical Trials – The mission of Lazarex Cancer Foundation is to give every person the … A fundraiser, Lazarex Impact 5.44k, is scheduled for April 27, 2019. Basically …
Learn More
March 20, 2019
Sue Hall speaks with members of Lazarex Cancer Foundation helping patients participate in Clinical Trials.
Learn More
February 18, 2019
Executive Provides Mentorship and Promotes Diversity at Genentech – Kenkare-Mitra sits on the board member of the Genentech Foundation, which is one way that she has been able to drive attempts to improve diversity at the Bay Area company.
Learn More
February 2019
February Newsletter: 2019 LCF Program Summary; 2018 Year End Appeal Surpasses Goal; Lazarex IMPACT 5.44K …
Newsletter
January 9, 2019
ASCO policy statement targets financial barriers to clinical trial participation – A policy statement issued by ASCO emphasizes the importance of increasing participation in cancer clinical research trials and outlines recommendations to improve access for underserved populations.
Learn More